Inflammation and angiogenesis are two hallmarks of carcinoma. The proinflammatory cytokine interleukin-17 (IL-17) facilitates angiogenesis in lung cancer; however, the underlying mechanism is not fully understood. In this study, tumour microvessel density (MVD) was positively associated with IL-17, interleukin-6 (IL-6), interleukin-8 (IL-8), and vascular endothelial cell growth factor (VEGF) expression in human lung adenocarcinoma tissues, and it was increased in tumour tissues of A549-IL-17 cell-bearing nude mice. Importantly, positive correlations were also detected between IL-17 expression and IL-6, IL-8 and VEGF expression in human lung adenocarcinoma tissues. Furthermore, IL-6, IL-8 and VEGF production, as well as STAT1 phosphorylation, were increased in tumour tissues of A549-IL-17 cellbearing nude mice in vivo and in A549 and H292 cells following IL-17 stimulation in vitro. In addition, STAT1 knockdown using an inhibitor and siRNA attenuated the IL-17-mediated increases in IL-6, IL-8 and VEGF expression in A549 and H292 cells. In conclusion, IL-17 may promote the production of the angiogenic inducers IL-6, IL-8 and VEGF via STAT1 signalling in lung adenocarcinoma.
experimental procedures were performed and approved in accordance with the relevant guidelines and regulations by the Animal Care and Use Committee of Tongji Medical College.
Male nude mice aged approximately 4-6 weeks were randomly allocated into two groups. The mice in one group were subcutaneously injected with A549-IL-17 cells (1 × 10 6 cells/mouse), and those in the other group were injected with A549-Neo cells (1 × 10 6 cells/mouse). The weights and tumour volumes (TVs) were measured for all mice every three days after their subcutaneous tumours became detectable. The TVs were calculated according to the following formula: TV (cm 3 ) = a × b 2 /2, where a and b are the longest and shortest diameters, respectively. All of the mice were sacrificed after receiving intraperitoneal anaesthesia with pentobarbital sodium (40 mg/kg in a 1% saline solution), which was administered at 36 days after injection to the nude mice. Fresh tumour tissues were fixed with paraformaldehyde before being embedded in paraffin.
Immunohistochemistry (IHC).
The procedure for IHC staining of tumour tissues from humans and mice was described previously 21 , and the following antibodies were used for this analysis: anti-human IL-17 and anti-human VEGF (1:100; Abcam, Cambridge, UK), anti-human IL-6 and anti-human IL-8 (1:100; Bioss, Beijing, China), and anti-CD31 (1:1; Maixin, Fujian, China). For MVD counting, MVD was determined based on the average of CD31 IHC staining positive cells counting. Cell membrane of vascular endothelial cells and (or) cytoplasm showed brown staining. MVD assessment and counting methods: low magnification visual wild find three select Pearson's correlation analysis was used to analyse the relationship between IL-17 mRNA expression and IL-6 (a), IL-8 (b), VEGF (c) mRNA expression in tumour tissues of patients with lung adenocarcinoma.. mRNA expression levels were calculated using the − Δ Δ Ct method, and target gene expression was normalized to the GAPDH housekeeping gene. microvessel most abundant of the "hot spots", and then high power field (x400) Counted, the average value as the specimen MVD (/field) were recorded by experienced observers in Department of Pathology of our hospital who were blind to the details of the patients. And IL-17, IL-6, IL8. Images were analysed as previously described 22 .
RNA interference. Human STAT1-siRNA (sc-44123) and human control-siRNA (sc-siRNA and sc-37007) were obtained from Santa Cruz Biotechnology. siRNAs were transfected into A549 and H292 cells using an siRNA Reagent System (sc-29528, Santa Cruz Biotechnology) at a final concentration of 80 nM for 48 h according to the manufacturer's protocol.
Western blotting (WB).
A549 and H292 cells (1 × 10 6 cells/well) were seeded in six-well plates overnight and were then exposed to the different treatments at the indicated time points. Cell lysates and tumour tissue homogenates were separated by SDS-PAGE and then transferred onto PVDF membranes (Millipore, USA). Next, WB was performed as previously described 23 . The following specific primary antibodies were used: anti-phospho-STAT1 (1:1000, Tyr701, CST#9167), anti-STAT1 (1:1000, Tyr701, CST#9167), anti-IL-6 (1:1000, 21865-1-AP), anti-IL-8 (1:1000, sc-1265; Santa Cruz Biotechnology), anti-VEGF (1:1000, BA0407; Boster, China), and anti-GAPDH (1:5000, BL1039; Wuhan, China).
Quantitative real-time PCR (qRT-PCR).
Total RNA was extracted from cells and tissues, and the extracted RNA was reverse transcribed and amplified by qRT-PCR as previously described 22 . The mRNA levels of the target genes were normalized to GAPDH. The sequences of the primers used for PCR are presented in Supplementary Table 1 (TS1).
Enzyme-linked immunosorbent assay (ELISA). A549 and H292 cells (1 × 10
5 cells/well) were exposed to the different treatments for 48 h, and then the IL-6, IL-8 and VEGF protein levels in the culture supernatants were measured using ELISA kits according to the manufacturer's protocols (all kits were purchased from R&D Systems, Minneapolis, MN). Statistics. The results are presented as the mean ± SEM. Differences were evaluated for significance using the t-test or one-way analysis of variance. Correlations were assessed in human lung adenocarcinoma tissue samples. Analyses were performed using SPSS statistical software version 16.0 (Chicago, IL), and a two-tailed p < 0.05 was considered to indicate statistical significance.
Results

MVD is positively related to IL-17, IL-6, IL-8, and VEGF expression in human lung adenocarcinoma.
Angiogenesis is coordinated by several types of molecules 5 , such as chemokines and cytokines. In our study, the relationship between IL-17, IL-6, IL-8, and VEGF and MVD determined by CD31 staining in human lung adenocarcinoma tissues was explored by qRT-PCR and IHC. Our results revealed that MVD was positively associated with IL-17, IL-6, IL-8, and VEGF protein expression in human lung adenocarcinoma tissues (Fig. 1A-J and Fig. 2A,B) . Furthermore, MVD was also positively correlated with the IL-17, IL-6, IL-8, and VEGF mRNA level ( Fig. 2E-H) , suggesting that IL-17, IL-6, IL-8, and VEGF may be involved in angiogenesis in human lung adenocarcinoma.
IL-17 is positively related to IL-6, IL-8, and VEGF expression in human lung adenocarcinoma.
Next, we evaluated the association of IL-17 expression with IL-6, IL-8, and VEGF expression in lung adenocarcinoma tissues by qRT-PCR and IHC. Our findings demonstrated that the mRNA and protein levels of IL-6, IL-8 and VEGF were positively correlated with those of IL-17 mRNA and protein, respectively (Fig. 3A,B) , indicating that IL-17 may induce angiogenesis by regulating the production of angiogenic factors IL-6, IL-8, and VEGF expression in human lung adenocarcinoma.
IL-17 facilitates IL-6, IL-8, and VEGF production in lung adenocarcinoma cells in vitro.
To determine the role of IL-17 in IL-6, IL-8, and VEGF expression in vitro, A549 and H292 cells were pretreated 6 cells/well) were treated with or without 100 ng/ml IL-17 for 6 h, and then STAT1 protein levels were determined by WB. Target gene expression was normalized to the Gapdh housekeeping gene, and the data from three independent experiments are presented. (C) A549/H292 cells cells (5 × 10 5 cells/well) were treated with or without 100 ng/ml IL-17 for 6 h, and then STAT1 mRNA levels were determined by qRT-PCR. mRNA expression levels were calculated using the 2 −ΔΔCt method, and target gene expression was normalized to the GAPDH housekeeping gene. The results shown are representative of four independent experiments and are presented the mean ± SEM. *p < 0.05 was regarded as significant. *Means p < 0.05, **means p < 0.01, ***means p < 0.001.
Scientific RepoRts | 6:36551 | DOI: 10.1038/srep36551 with IL-17 (100 ng/ml) for 6 h, and then the IL-6, IL-8 and VEGF mRNA and protein levels were measured by qRT-PCR and ELISA. As expected, the IL-6, IL-8 and VEGF mRNA levels were increased by 8.2-, 3.6-, and 3.9-fold in A549 cells following treatment with IL-17 compared to treatment with medium alone (Fig. 4A) . These results were further confirmed by ELISA (Fig. 4B) . Similar increases were observed in vitro in H292 cells pretreated with IL-17 compared with medium. Taken together, these data indicate that IL-17 may promote IL-6, IL-8 and VEGF production in human lung adenocarcinoma in vitro.
IL-17 activates STAT1 phosphorylation in lung adenocarcinoma cells in vitro.
The biological effects of IL-17 have been shown to involve the Jak-Stat family. Thus, we further explored the possibility that IL-17 might modulate STAT1 phosphorylation in human lung adenocarcinoma cells. We determined the role of IL-17 in STAT1 phosphorylation in human lung adenocarcinoma cells in vitro by qRT-PCR and WB. As observed, STAT1 phosphorylation was increased in A549 cells following treatment with IL-17 compared to treatment with medium alone (Fig. 5A,B) by WB. Similar results were observed in H292 cells. And these data were proved at mRNA level in A549 and H292 (Fig. 5C ). These results suggest that IL-17 activates STAT1 signalling in human lung adenocarcinoma cells in vitro.
STAT1 knockdown attenuates IL-17-induced IL-6, IL-8, and VEGF expression in lung adenocarcinoma cells in vitro.
To examine the effects of STAT1 on IL-17-induced IL-6, IL-8 and VEGF expression in A549 and H292 cells, a STAT1 inhibitor, fludarabine, and STAT1 siRNA were used to selectively inhibit STAT1 signalling. Our data suggested that fludarabine inhibits IL-17-induced IL-6, IL-8 and VEGF mRNA expression in both A549 and H292 cells (Fig. 6A) . These findings were further confirmed by ELISA (Fig. 6B) . In addition, transfection of A549 or H292 cells with STAT1 siRNA for 48 h resulted in effective STAT1 knockdown and a marked reduction in its activation, as determined by qRT-PCR and WB (Fig. 7A,B) . The effects of STAT1 siRNA on A549 cells were similar to those of fludarabine and considerably attenuated the IL-17-mediated increases in Figure 6 . STAT1 inhibitor attenuated IL-17-induced IL-6, IL-8, and VEGF production in human lung adenocarcinoma. A549/H292 cells were incubated with IL-17 or IL-17 plus a STAT1 inhibitor for 6 or 48 h (100 ng/ml IL-17; and 30 μ M inhibitor). The IL-6, IL-8, and VEGF mRNA and protein levels were determined by qRT-PCR and ELISA, respectively. (A) IL-6, IL-8, and VEGF mRNA levels in A549/H292 cells, mRNA expression levels were calculated using the 2 −ΔΔCt method, and target gene expression was normalized to the GAPDH housekeeping gene. The data are presented as the mean ± SEM of three independent experiments. (B) IL-6, IL-8, and VEGF protein levels in A549/H292 cells. The data are presented as the mean ± SEM of three independent experiments. Comparisons were performed using the t-test. *p < 0.05; **p < 0.01; and ***p < 0.001.
Scientific RepoRts | 6:36551 | DOI: 10.1038/srep36551 IL-6, IL-8 and VEGF mRNA and protein expression compared to control siRNA, as determined by qRT-PCR and WB (Fig. 7C,D) . Similar results were obtained in H292 cells. These findings suggest that STAT1 inhibits the IL-17-mediated elevations in IL-6, IL-8 and VEGF production in lung adenocarcinoma in vitro. Fig. 8A,B) , suggesting that IL-17 may support tumour growth in vivo. Then, we determined if IL-17 increases MVD in vivo by performing CD31 staining in these mice. As expected, higher tumour vascularity was observed in the tumour tissues of the A549-IL-17 cell-bearing nude mice compared with the controls (Fig. 8C,D) . These data provide evidence that IL-17 may promote tumor vascularity in vivo.
IL-17 induces MVD in tumour tissues
IL-17 promotes IL-6, IL-8, VEGF and STAT1 phosphorylation in A549-IL-17 cell-bearing nude mice in vivo.
Given the correlation between IL-17 and MVD in vivo, we further assessed IL-6, IL-8 and VEGF production in A549-IL-17 cell-bearing nude mice by qRT-PCR and WB. IL-6, IL-8 and VEGF mRNA levels were increased by 2.3-, 4.1-, and 1.3-fold, respectively, in the tumour tissues of the A549-IL-17 cell-bearing nude mice compared with the mRNA levels in the controls (Fig. 9A) . Similar changes in the protein levels were also observed (Fig. 9B) . These results indicate that IL-17 promotes IL-6, IL-8 and VEGF expression in IL-17-overexpressing nude mice. The biological effects of IL-17 have been shown to involve the Jak-Stat family. In the present study, STAT1 phosphorylation in A549-IL-17 cell-bearing nude mice was measured by qRT-PCR and WB. STAT1 expression was slightly increased in the A549-IL-17 cell-bearing nude mice compared with controls (Fig. 9A,B) , implying that IL-17 influences Stat1 expression in vivo. 5 cells/well) were transfected with siRNA for 48 h and subsequently treated with human IL-17 (100 ng/ml) for an additional 6 or 48 h. The IL-6, IL-8, and VEGF mRNA and protein expression levels were determined by qRT-PCR and WB, respectively. (B) IL-6, IL-8, VEGF mRNA levels in A549/H292 cells. mRNA expression levels were calculated using the 2 −ΔΔCt method, and target gene expression was normalized to the GAPDH housekeeping gene. The data are presented as the mean ± SEM of three independent experiments. (C) IL-6, IL-8, and VEGF protein levels in A549/H292 cells and the results are presented as the mean ± SEM of three independent experiments. Comparisons were performed using the t-test. *p < 0.05; **p < 0.01; and ***p < 0.001.
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Discussion
In our study, MVD evaluated by CD31 staining was correlated with IL-17 expression in human lung adenocarcinoma tissues, as determined by qRT-PCR and IHC. Similarly, previous studies have confirmed that high IL-17 expression is significantly associated with high MVD by CD31 or CD34 staining in many types of tumours, such as human ovarian cancer 24, 25 , hepatocellular carcinoma 26 , multiple myeloma 27 , colorectal carcinoma 28 , cholangiocarcinoma tumours 29 and NSCLC 7 . Moreover, our CD31 staining results suggest that IL-17 increased MVD in A549-IL-17 cell-bearing nude mice. These findings are in agreement with a previous study 7 7 have demonstrated that IL-17 increases IL-6 and IL-8 expression in A549, Sq-19 and LK-87 cells but that VEGF production is not altered in these three cell lines using ELISA. In contrast, Li Q et al. 15 have reported that IL-17 increases VEGF expression in A549 cells using WB, and Li Y et al. 35 have also found that IL-17 also promotes VEGF release from 95C and 95D cells using ELISA. The discrepancies regarding VEGF production among these previous studies may be partly attributed to differences in laboratory conditions or to the varying sensitivities of the different ELISA kits used. However, the mechanisms of the effects of IL-17 on IL-6, IL-8 and VEGF expression in the A549 cell line have not been previously elucidated.
Furthermore, we found that the STAT1 signalling pathway was involved in the IL-17-mediated induction of IL-6, IL-8 and VEGF expression in the A549 cells. In addition, we observed increased phosphorylation of p-STAT1 signalling in A549-IL-17 cell-bearing nude mice and in A549 cells following IL-17 stimulation. Accumulating evidence indicates that IL-17 directly communicates with the Jak/Stat and PI3K/Akt signalling pathways and that it also targets NF-kB, AP-1 and Sp1 in many tumour types 12, 36 . For example, IL-17 has been reported to directly activate the tyrosine phosphorylation of STAT1, STAT2, STAT3 and STAT4 in human U937 monocytic leukaemia cells 37 and of STAT1 and Stat3 in HaCaT cells 38 . In addition, previous studies have shown that Stat3/Akt regulates IL-6 production 20 , Akt modifies IL-8 39 release, and Stat3/Akt modulate VEGF expression in lung cancer cell lines 39, 40 . We therefore examined whether Stat1 participates in IL-17-induced angiogenic factor production in lung adenocarcinoma. As expected, STAT1 knockdown partially inhibited IL-17-mediated IL-6, IL-8, and VEGF production in human lung adenocarcinoma cell lines in vitro, suggesting communication between STAT1 signalling and IL-17 in lung adenocarcinoma.
In conclusion, we have revealed that IL-17 promotes IL-6, IL-8, and VEGF production in lung adenocarcinoma via STAT1 signalling. IL-6 41 , IL-8 42 , and VEGF 43 are multifunctional cytokines that are regarded as biomarkers and are strongly associated with multiple aspects of lung cancer. Given the crosstalk that occurs between proinflammatory signalling pathways and IL-6, IL-8, and VEGF, as well as the pivotal roles of angiogenic factors in lung cancer, our work may facilitate the design of therapeutic interventions targeting both inflammation and angiogenesis in lung cancer in the future. . mRNA expression levels were calculated using the 2 −ΔΔCt method, and target gene expression was normalized to the GAPDH housekeeping gene. The data are presented as the mean ± SEM for five mice per group, and the results are representative of two independent experiments. *p < 0.05; **p < 0.01; and ***p < 0.001.
